STOCK TITAN

MDGL stock (NASDAQ: MDGL) in Rule 144 planned 18650-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MDGL filed a Rule 144 notice covering the planned sale of 18650 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

These shares were acquired on 01/09/2026 by exercising stock options for cash and have an aggregate market value of 10373503.00. The issuer reports 22711420 shares outstanding. In the past three months, 10b5-1 sales disclosed include 18650 shares for Rebecca A Taub with gross proceeds of 10297573.26 and 24800 shares for Paul A Friedman with gross proceeds of 13694158.24.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MDGL Rule 144 filing disclose?

The filing discloses a planned sale of 18650 shares of MDGL common stock under Rule 144 through Morgan Stanley Smith Barney LLC on NASDAQ.

How many MDGL shares are planned to be sold under this Rule 144 notice?

The notice covers the planned sale of 18650 shares of MDGL common stock.

How were the MDGL shares being sold under Rule 144 acquired?

The 18650 MDGL common shares were acquired on 01/09/2026 through the exercise of stock options, with the purchase price paid in cash.

What prior 10b5-1 sales related to MDGL are disclosed in the past three months?

Disclosed 10b5-1 sales include 18650 shares for Rebecca A Taub with gross proceeds of 10297573.26 and 24800 shares for Paul A Friedman with gross proceeds of 13694158.24, both on 12/10/2025.

How many MDGL shares are reported as outstanding in this filing?

The filing reports 22711420 shares of MDGL common stock outstanding.

Which broker and exchange are involved in the MDGL Rule 144 sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.
Madrigal Pharmac

NASDAQ:MDGL

MDGL Rankings

MDGL Latest News

MDGL Latest SEC Filings

MDGL Stock Data

11.26B
20.97M
7.7%
107.92%
18.16%
Biotechnology
Pharmaceutical Preparations
Link
United States
WEST CONSHOHOCKEN